"Vitamin E" fortified parenteral lipid emulsions: Plackett-Burman screening of primary process and composition parameters

Drug Development and Industrial Pharmacy

Volumn 39, Issue 2, 2013, Pages 363-373

  Alayoubi, Alaadin ^a   Nazzal, Mahmoud ^b   Sylvester, Paul W ^a   Nazzal, Sami ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Emulsion; Experimental design; Plackett Burman; Screening; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; EMULSIFYING AGENT; LIPID EMULSION; MEDIUM CHAIN TRIACYLGLYCEROL;

ANALYTIC METHOD; ARTICLE; DRUG FORMULATION; DRUG STABILITY; PARTICLE SIZE; PLACKETT BURMAN SCREENING DESIGN; TEMPERATURE; VISCOSITY;

CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; EMULSIONS; LIPIDS; PARENTERAL NUTRITION; PARTICLE SIZE; VISCOSITY; VITAMIN E;

EID: 84872440085     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.682223     Document Type: Article

References (42)

1. Driscoll DF, Nehne J, Peterss H, Franke R, Bistrian BR, Niemann W. (2002). The influence of medium-chain triglycerides on the stability of all-in-one formulations. Int J Pharm, 240:1-10. (Pubitemid 34607697)
2. Cukier C, Waitzberg DL, Logullo AF, Bacchi CE, Travassos VH, Torrinhas RS et al. (1999). Lipid and lipid-free total parenteral nutrition: differential effects on macrophage phagocytosis in rats. Nutrition, 15:885-889. (Pubitemid 29518475)
3. Constantinides PP, Tustian A, Kessler DR. (2004). Tocol emulsions for drug solubilization and parenteral delivery. Adv Drug Deliv Rev, 56:1243-1255. (Pubitemid 38510472)
4. Li J, Nie S, Yang X, Wang C, Cui S, Pan W. (2008). Optimization of tocol emulsions for the intravenous delivery of clarithromycin. Int J Pharm, 356:282-290.
5. Jumaa M, Müller BW. (2002). Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability. Eur J Pharm Biopharm, 54:207-212. (Pubitemid 34919395)
6. Manuel-y-Keenoy B, Nonneman L, De Bosscher H, Vertommen J, Schrans S, Klütsch K, De Leeuw I. (2002). Effects of intravenous supplementation with atocopherol in patients receiving total parenteral nutrition containing medium-and long-chain triglycerides. Eur J Clin Nutrition, 56:121-128. (Pubitemid 34145154)
7. Télessy IG, Balogh J, Csempesz F, Szente V, Dredán J, Zelkó R. (2009). Comparison of the physicochemical properties of MCTcontaining fat emulsions in total nutrient admixtures. Colloids Surf B Biointerfaces, 72:75-79.
8. Constantinides PP, Han J, Davis SS. (2006). Advances in the use of tocols as drug delivery vehicles. Pharm Res, 23:243-255. (Pubitemid 43237855)
9. Han J, Davis SS, Papandreou C, Melia CD, Washington C. (2004). Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stability. Pharm Res, 21:1573-1580. (Pubitemid 41184387)
10. Kato Y, Watanabe K, Nakakura M, Hosokawa T, Hayakawa E, Ito K. (1993). Blood clearance and tissue distribution of various formulations of α-tocopherol injection after intravenous administration. Chem Pharm Bull, 41:599-604. (Pubitemid 23144554)
11. Rajendran A, Palanisamy A, Thangavelu V. (2008). Evaluation of medium components by Plackett-Burman statistical design for lipase production by Candida rugosa and kinetic modeling. Sheng Wu Gong Cheng Xue Bao, 24:436-444. (Pubitemid 351467208)
12. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. (2007). Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. Int J Pharm, 332:55-63. (Pubitemid 46227776)
13. Yu LX. (2008). Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res, 25:781-791.
14. Snee RD, Cini P, Kamm JJ, Meyers CA. (2008). Quality by design: shortening the path to acceptance. The Free Library.
15. Arnum PV. (2007). A FDA Perspective on Quality by Design. Pharmaceutical Technology Sourcing and Management.
16. Verma S, Lan Y, Gokhale R, Burgess DJ. (2009). Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm, 377:185-198.
17. Shah RB, Zidan AS, Funck T, Tawakkul MA, Nguyenpho A, Khan MA. (2007). Quality by design: characterization of self-nanoemulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J Pharm, 341:189-194. (Pubitemid 47096679)
18. Rajendran A, Thangavelu V. (2007). Sequential optimization of culture medium composition for extracellular lipase production by Bacillus sphaericus using statistical methods. J Chem Technol Biotechnol, 82:460-470. (Pubitemid 46864961)
19. Sastry SV, Khan MA. (1998). Aqueous based polymeric dispersion: Plackett-Burman design for screening of formulation variables of atenolol gastrointestinal therapeutic system. Pharm Acta Helv, 73:105-112. (Pubitemid 28327972)
20. El-Malah Y, Nazzal S. (2006). Hydrophilic matrices: application of Placket-Burman screening design to model the effect of POLYOXcarbopol blends on drug release. Int J Pharm, 309:163-170. (Pubitemid 43129479)
21. Murray J. (1994). X-Stat, Version 2.02. Statistical Experimentation Design, Data Analysis and Nonlinear Optimisation. 2.02. ed. Hoboken, New Jersey, USA: John Wiley and Sons.
22. Jumaa M, Müller BW. (2001). Development of a novel parenteral formulation for tetrazepam using a lipid emulsion. Drug Dev Ind Pharm, 27:1115-1121. (Pubitemid 34053207)
23. Cheong JN, Tan CP, Man YBC, Misran M. (2008). α-Tocopherol nanodispersions: Preparation, characterization and stability evaluation. J Food Engg, 89:204-209.
24. Floury J, Desrumaux A, Lardières J. (2000). Effect of high-pressure homogenization on droplet size distributions and rheological properties of model oil-in-water emulsions. Innov Food Sci Emerg Technol, 1:127-134.
25. Tadros TF. (2005). Applied Surfactants: Principles and Applications. Weinheim, Germany: Wiley-VCH.
26. Lai HS, Lin WH, Wu HC, Chang KJ, Chen WJ. (2005). Effects of a medium-chain triacylglycerol/long-chain triacylglycerol fat emulsion containing a reduced ratio of phospholipid to triacylglycerol in pediatric surgical patients. Nutrition, 21:825-830.
27. Deckelbaum RJ, Hamilton JA, Moser A, Bengtsson-Olivecrona G, Butbul E, Carpentier YA et al. (1990). Medium-chain versus longchain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: implications for the mechanisms of lipase action. Biochemistry, 29:1136-1142. (Pubitemid 20053833)
28. Deckelbaum RJa, Calder PCb, Carpentier YAc. (2004). Using different intravenous lipids: underutilized therapeutic approaches? [Miscellaneous]. Curr Opin Clin Nutrition Metabol Care, 7:113-115.
29. Ton MN, Chang C, Carpentier YA, Deckelbaum RJ. (2005). In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides. Clin Nutr, 24:492-501. (Pubitemid 41051902)
30. Jumaa M, Müller BW. (1998). The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int J Pharm, 163:81-89. (Pubitemid 28162622)
31. Floury J, Desrumaux A, Legrand J. Effect of ultra-high-pressure homogenization on structure and on rheological properties of soy protein-stabilized emulsions. (2002). J Food Sci, 67:3388-3395. (Pubitemid 36029077)
32. Mulder H, Walstra P. (1974). The milk fat globule: emulsion science as applied to milk products and comparable foods. Commonwealth Agricultural Bureaux.
33. Desrumaux A, Marcand J. (2002). Formation of sunflower oil emulsions stabilized by whey proteins with high-pressure homogenization (up to 350 MPa): effect of pressure on emulsion characteristics. Int J Food Sci Technol, 37:263-269. (Pubitemid 36840519)
34. Palanuwech J, Coupland JN. (2003). Effect of surfactant type on the stability of oil-in-water emulsions to dispersed phase crystallization. Colloid Surfaces Physicochem Eng Aspect, 223:251-262. (Pubitemid 36952336)
35. Osborn HT, Akoh CC. (2004). Effect of emulsifier type, droplet size, and oil concentration on lipid oxidation in structured lipid-based oil-in-water emulsions. Food Chem, 84:451-456. (Pubitemid 37372019)
36. Megli FM, Conte E, Ishikawa T. (2011). Cholesterol attenuates and prevents bilayer damage and breakdown in lipoperoxidized model membranes. A spin labeling EPR study. Biochim Biophys Acta, 1808:2267-2274.
37. Redgrave TG, Vassiliou GG, Callow MJ. (1987). Cholesterol is necessary for triacylglycerol-phospholipid emulsions to mimic the metabolism of lipoproteins. Biochim Biophys Acta, 921:154-157. (Pubitemid 17134686)
38. Maranhao RC, Tercyak AM, Redgrave TG. (1986). Effects of cholesterol content on the metabolism of protein-free emulsion models of lipoproteins. Biochim Biophys Acta, 875:247-255. (Pubitemid 16149047)
39. Lenzo NP, Martins I, Mortimer BC, Redgrave TG. (1988). Effects of phospholipid composition on the metabolism of triacylglycerol, cholesteryl ester and phosphatidylcholine from lipid emulsions injected intravenously in rats. Biochim Biophys Acta, 960:111-118.
40. Sünder A, Scherze I, Muschiolik G. (2001). Physico-chemical characteristics of oil-in-water emulsions based on whey protein-phospholipid mixtures. Colloids Surf B Biointerfaces, 21:75-85. (Pubitemid 32500308)
41. Huang C, Li S. (1999). Calorimetric and molecular mechanics studies of the thermotropic phase behavior of membrane phospholipids. Biochim Biophys Acta, 1422:273-307. (Pubitemid 29512381)
42. Lasic DD. (1997). Liposomes in Gene Delivery.Boca Raton, FL, USA: CRC Press.